Clinical trials
Moderna-Merck Cancer Vaccine
Moderna and Merck's individualized cancer vaccine shows promise in Phase 3 trial for melanoma
BioPharma Dive
A source referenced in Bench to Bed coverage of Medical Research. Stories crediting this source are aggregated and rewritten by the Bench to Bed editorial team, linked to the original report where available.